Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
NORCROSS, Ga., May 15, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:…
Madrigal Announces New Clinical Data Demonstrating Rezdiffra (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the…
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its…
INP and Fight For Life Club Foundation Make History: Two Pediatric Living Donor Liver Transplants in One Week
Dallas, Texas, May 02, 2025 (GLOBE NEWSWIRE) -- In a historic medical…
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells May 01,…
Press release: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation
Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver…
Press release: Sequana Medical announces 2024 Full Year Results and 2025 Outlook
Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® –…
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
March 03, 2025 06:00 ET | Source: Can-Fite BioPharma Ltd. Unlike chemotherapy…
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) --…
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx)…